Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM; JEWEL Study Group. Hobbs FD, et al. Among authors: bohler s. Int J Cardiol. 2006 Jun 16;110(2):242-50. doi: 10.1016/j.ijcard.2005.10.017. Epub 2005 Dec 9. Int J Cardiol. 2006. PMID: 16338012
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk.
Schneider HJ, Glaesmer H, Klotsche J, Böhler S, Lehnert H, Zeiher AM, März W, Pittrow D, Stalla GK, Wittchen HU; DETECT Study Group. Schneider HJ, et al. Among authors: bohler s. J Clin Endocrinol Metab. 2007 Feb;92(2):589-94. doi: 10.1210/jc.2006-0254. Epub 2006 Nov 14. J Clin Endocrinol Metab. 2007. PMID: 17105840
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider HJ, Lehnert H, Böhler S, Koch U, Wittchen HU. Pittrow D, et al. Among authors: bohler s. Med Klin (Munich). 2006 Aug 15;101(8):635-44. doi: 10.1007/s00063-006-1093-x. Med Klin (Munich). 2006. PMID: 16896570 German.
[Cardiovascular high-risk constellations in primary care. DETECT Study 2003].
Pieper L, Wittchen HU, Glaesmer H, Klotsche J, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D, Ruf G. Pieper L, et al. Among authors: bohler s. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Dec;48(12):1374-82. doi: 10.1007/s00103-005-1164-9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005. PMID: 16283123 Clinical Trial. German.
Recognition and management of overweight and obesity in primary care in Germany.
Bramlage P, Wittchen HU, Pittrow D, Kirch W, Krause P, Lehnert H, Unger T, Höfler M, Küpper B, Dahm S, Böhler S, Sharma AM. Bramlage P, et al. Among authors: bohler s. Int J Obes Relat Metab Disord. 2004 Oct;28(10):1299-308. doi: 10.1038/sj.ijo.0802752. Int J Obes Relat Metab Disord. 2004. PMID: 15314629
All-cause mortality and serum insulin-like growth factor I in primary care patients.
Friedrich N, Schneider H, Dörr M, Nauck M, Völzke H, Klotsche J, Sievers C, Pittrow D, Böhler S, Lehnert H, Pieper L, Wittchen HU, Wallaschofski H, Stalla GK. Friedrich N, et al. Among authors: bohler s. Growth Horm IGF Res. 2011 Apr;21(2):102-6. doi: 10.1016/j.ghir.2011.02.003. Epub 2011 Mar 23. Growth Horm IGF Res. 2011. PMID: 21435927
Drug interactions with angiotensin receptor blockers.
Böhler S, Pittrow D, Bramlage P, Kirch W. Böhler S, et al. Expert Opin Drug Saf. 2005 Jan;4(1):7-18. doi: 10.1517/14740338.4.1.7. Expert Opin Drug Saf. 2005. PMID: 15709894 Review.
55 results